Elon Musk, one of President-elect Donald Trump’s top aides, on Wednesday expressed support for weight-loss drugs like Ozempic to be made available to the general public at low prices — a move that would require the Secretary of Health and Human Services to This contrasted with comments made by nominee Robert F. Kennedy Jr. I made it.
“Nothing can help improve Americans’ health, longevity, and quality of life more than by making GLP inhibitors available to Americans at ultra-low prices,” Musk said. I wrote to X. “There’s nothing else like it.”
President Biden’s Department of Health and Human Services announced in late November that it would move forward with a plan to provide coverage for weight-loss drugs to people covered by federal benefit programs such as Medicare and Medicaid.
But given the short time left in President Biden’s term, the future of waistline-reducing drugs will rest with the incoming Trump administration, raising questions about who will make the final decision.
A vocal opponent of Ozempic, Kennedy Jr., before being nominated as Secretary of Health and Human Services, urged the incoming administration to “make America healthy again.”
In an interview with Fox News’ Greg Gutfeld, President Kennedy mocked the high cost of making Ozempic available to everyone who is overweight, claiming it would cost “$3 trillion a year.” .
“If we spent a fifth of that and gave every man, woman and child in our country three meals a day, we could solve the obesity and diabetes epidemic overnight,” said the 70-year-old Health First. The person spoke.
GLP inhibitors are a type of drug that help regulate blood sugar and insulin levels in diabetics, but Americans have been using a range of drugs, including Ozempic, for weight loss.
Musk acknowledged that his view that the drug is cheap could cause a ripple.
“A lot of people will complain about this post, but I’m right,” he added to X.
In response to Musk’s opinion, X-personality Gail Alfer said, “Elon Musk is right. 40% of Americans suffer from obesity, and 9% have a BMI over 40. “This is extremely dangerous for our health.” This needs to be fixed. GLP-1 receptor agonists are too expensive for most people who need them. ”
“Gail is right,” replied the richest man in the world.
Although Musk currently holds no position directly impacting drug regulation, his constant presence alongside Trump has allowed him to make policy proposals and encourage some political appointees.
President Kennedy’s press secretary did not immediately respond to inquiries from the Post.
